Strategic Partnerships STAR Apollo maps atrial fibrillation in real time by analyzing data from existing electrophysiology systems with AI-driven patterns. This enables lab teams to craft personalized ablation strategies and accelerates conversations with potential customers about upgrading workflows. Leverage Biosense Webster collaboration as validation of cross‑vendor interoperability and use industry events like AF Symposium 2026 to demonstrate live cases to prospective customers and partners.

Market Expansion Rhythm AI is London-based with a lean team, presenting a scalable product to mid to large EP labs across the UK and EU. Focus on entering hospital and academic centers via pilots, partnerships with regional distributors, and integration with existing EP workflows to reduce switching costs. The leadership change to CEO Mike Dineen and ongoing funding provide a narrative for fast market entry and commitments to enterprise customers.

Live Demo Channel Industry events and live-case transmissions are a clear channel for customer education and deal acceleration. The AF Symposium 2026 live case transmission of STAR Apollo offers a ready-to-use asset for sales teams to book demonstrations, generate physician interest, and convert to early access programs or pilots in target accounts.

Funding Momentum Funding momentum and a clear path to revenue through pilots and multi-vendor deployments position Rhythm AI as an attractive partner for hospitals and distributors. Seed financing and overall funding support co-development, regional pilots, and expansion initiatives with medical device distributors and system integrators.

Differentiation Edge STAR Apollo's AI-driven mapping anchored in electrophysiology principles aims to improve ablation precision and personalized treatment. This differentiation can shorten procurement cycles through co-development or exclusive distribution talks with larger partners in key markets.